| Today's Open | $6.78 |
|---|---|
| Previous Close | $6.85 |
| Daily Range | $6.26 - $6.78 |
| 52-Week Range | $1.65 - $6.99 |
| Market Cap | $1.9B |
| P/E Ratio | -8.35 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 12,747,614 |
| Average Daily Volume | 6,568,419 |
| Current FY EPS | -$0.49 |
Sector
Healthcare
Industry
Drugs
MannKind Corp (MNKD) Description
A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer. Website: http://www.mannkindcorp.com/
News & Commentary
But where will this stock's run end?
A major battle looms as leading insulin products lose patent protection. Here are the likely winners and losers of the coming diabetes wars.
5 of Last Week's Biggest Winners
These five companies posted double-digit gains this past week.MNKD's Top Competitors
(-4.74%)
(-0.18%)
(0.11%)
(0.83%)